TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
29.03
-0.16 (-0.55%)
At close: Mar 5, 2026, 4:00 PM EST
28.72
-0.31 (-1.07%)
Pre-market: Mar 6, 2026, 8:03 AM EST
TG Therapeutics Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for TG Therapeutics stock have an average target of 50.67, with a low estimate of 39 and a high estimate of 60. The average target predicts an increase of 74.54% from the current stock price of 29.03.
Analyst Consensus: Strong Buy
* Price targets were last updated on Feb 2, 2026.
Analyst Ratings
The average analyst rating for TG Therapeutics stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 6 | 5 | 5 | 5 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $49 → $46 | Buy | Maintains | $49 → $46 | +58.46% | Feb 2, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $37 → $39 | Hold | Maintains | $37 → $39 | +34.34% | Jan 15, 2026 |
| JP Morgan | JP Morgan | Buy Maintains $46 → $49 | Buy | Maintains | $46 → $49 | +68.79% | Nov 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $60 | Strong Buy | Initiates | $60 | +106.68% | Oct 6, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $53 → $55 | Strong Buy | Maintains | $53 → $55 | +89.46% | Sep 17, 2025 |
Financial Forecast
Revenue This Year
916.72M
from 616.29M
Increased by 48.75%
Revenue Next Year
1.15B
from 916.72M
Increased by 25.01%
EPS This Year
1.61
from 2.77
Decreased by -41.96%
EPS Next Year
2.33
from 1.61
Increased by 45.07%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 963.9M | 1.3B | |||
| Avg | 916.7M | 1.1B | |||
| Low | 858.0M | 925.1M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 56.4% | 41.5% | |||
| Avg | 48.7% | 25.0% | |||
| Low | 39.2% | 0.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 2.02 | 3.35 | |||
| Avg | 1.61 | 2.33 | |||
| Low | 1.24 | 1.80 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -27.2% | 108.3% | |||
| Avg | -42.0% | 45.1% | |||
| Low | -55.1% | 12.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.